Premature Labor
In a surprise result, a study of a drug designed to lower the risk of premature birth was shown to be no better than a placebo. Update, October 30, 2019 An FDA Advisory Committee met to review Makena (17-α hydroxyprogesterone injection or 17-OHPC) in light of the new post-approval study…
Don’t miss the info about “incidental findings.” It could save you from too much medicine. And enjoy the report on how human contact wins over medicine with dementia patients.
